Directorate Change | 11-Aug-2023 | 12:04 | RNS |
Result of AGM | 30-Jun-2023 | 13:12 | RNS |
Lupuzor Update | 19-Jun-2023 | 07:00 | RNS |
IMM RNS Posting of RA and Notice of AGM 30 June 23 | 06-Jun-2023 | 07:00 | RNS |
Positive Pre-IND meeting with FDA | 18-May-2023 | 07:00 | RNS |
Final Results | 11-May-2023 | 07:00 | RNS |
Holding(s) in Company | 10-May-2023 | 13:56 | RNS |
Lupozor Update - FDA confirms Type-C meeting date | 19-Apr-2023 | 07:00 | RNS |
CIDP P140 Clinical Program Update | 12-Apr-2023 | 07:00 | RNS |
Lupuzor™ Update | 27-Mar-2023 | 07:00 | RNS |
Price Monitoring Extension | 09-Mar-2023 | 16:35 | RNS |
Collaboration with Orano on ImmuPharma Peptide | 06-Mar-2023 | 07:00 | RNS |
Lupuzor™ Update | 06-Feb-2023 | 07:00 | RNS |
TR-1: Notification of major holdings | 27-Jan-2023 | 16:25 | RNS |
TR-1: Notification of major holdings | 04-Jan-2023 | 17:26 | RNS |
Currency | UK Pounds |
Share Price | 2.14p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 3.42 |
52 Week Low | 0.85 |
Volume | 604,698 |
Shares Issued | 416.44m |
Market Cap | £8.91m |
RiskGrade | 328 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:55 | 20,000 @ 2.14p |
15:13 | 60,201 @ 2.14p |
13:57 | 25,000 @ 2.14p |
13:54 | 50,000 @ 2.14p |
12:33 | 603 @ 2.20p |
You are here: research